🇺🇸 FDA
Patent

US 12109197

Combinations of β-lactam compounds and probenecid and uses thereof

granted A61KA61K31/145A61K31/195

Quick answer

US patent 12109197 (Combinations of β-lactam compounds and probenecid and uses thereof) held by Iterum Therapeutics International Limited expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Iterum Therapeutics International Limited
Grant date
Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/145, A61K31/195, A61K31/407, A61K31/424